May measurement month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

MMM Investigators

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

AIMS: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. METHODS AND RESULTS: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. CONCLUSION: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.

Original languageEnglish
Pages (from-to)2006-2017
Number of pages12
JournalEuropean Heart Journal
Volume40
Issue number25
DOIs
Publication statusPublished - 1 Jul 2019

Fingerprint

Blood Pressure
Hypertension
Antihypertensive Agents
Reading
Life Style
Volunteers
Demography
Mortality

Cite this

@article{9b52bc1781a948fb93fa42709af82e17,
title = "May measurement month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension",
abstract = "AIMS: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. METHODS AND RESULTS: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9{\%} of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4{\%} female) were screened. After multiple imputation, 502 079 (33.4{\%}) individuals had hypertension, of whom 59.5{\%} were aware of their diagnosis and 55.3{\%} were taking antihypertensive medication. Of those on medication, 60.0{\%} were controlled and of all hypertensives, 33.2{\%} were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. CONCLUSION: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.",
keywords = "Blood pressure, Control, Global, Hypertension, Screening, Treatment",
author = "{MMM Investigators} and Thomas Beaney and Burrell, {Louise M.} and Castillo, {Rafael R.} and Charchar, {Fadi J.} and Suzie Cro and Albertino Damasceno and Ruan Kruger and Nilsson, {Peter M.} and Dorairaj Prabhakaran and Ramirez, {Agustin J.} and Schlaich, {Markus P.} and Schutte, {Aletta E.} and Maciej Tomaszewski and Rhian Touyz and Wang, {Ji Guang} and Weber, {Michael A.} and Poulter, {Neil R.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1093/eurheartj/ehz300",
language = "English",
volume = "40",
pages = "2006--2017",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "OXFORD UNIV PRESS UNITED KINGDOM",
number = "25",

}

May measurement month 2018 : a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. / MMM Investigators.

In: European Heart Journal, Vol. 40, No. 25, 01.07.2019, p. 2006-2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - May measurement month 2018

T2 - a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

AU - MMM Investigators

AU - Beaney, Thomas

AU - Burrell, Louise M.

AU - Castillo, Rafael R.

AU - Charchar, Fadi J.

AU - Cro, Suzie

AU - Damasceno, Albertino

AU - Kruger, Ruan

AU - Nilsson, Peter M.

AU - Prabhakaran, Dorairaj

AU - Ramirez, Agustin J.

AU - Schlaich, Markus P.

AU - Schutte, Aletta E.

AU - Tomaszewski, Maciej

AU - Touyz, Rhian

AU - Wang, Ji Guang

AU - Weber, Michael A.

AU - Poulter, Neil R.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - AIMS: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. METHODS AND RESULTS: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. CONCLUSION: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.

AB - AIMS: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. METHODS AND RESULTS: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. CONCLUSION: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.

KW - Blood pressure

KW - Control

KW - Global

KW - Hypertension

KW - Screening

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85069236245&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehz300

DO - 10.1093/eurheartj/ehz300

M3 - Article

VL - 40

SP - 2006

EP - 2017

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 25

ER -